0000950123-23-011100.txt : 20231129
0000950123-23-011100.hdr.sgml : 20231129
20231129161928
ACCESSION NUMBER: 0000950123-23-011100
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20231129
DATE AS OF CHANGE: 20231129
EFFECTIVENESS DATE: 20231129
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-498379
FILM NUMBER: 231452469
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
D
1
primary_doc.xml
X0708
D
LIVE
0001878313
MAIA Biotechnology, Inc.
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
312-416-8592
DELAWARE
None
None
Corporation
true
Vlad
Vitoc
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Executive Officer
Director
Chief Executive Officer
Jeffrey
C
Himmelreich
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Executive Officer
Head of Finance
Jean-Manasse
Theagene
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Director
Steven
M
Chaouki
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Director
Stan
Smith
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Director
Sergei
Gryaznov
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Executive Officer
Chief Scientific Officer
Ramiro
Guerrero
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Director
Ngar
Yee
Louie
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Director
Cristian
Luput
444 West Lake Street
Suite 1700
Chicago
IL
ILLINOIS
60606
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-11-15
false
true
true
true
false
0
H.C. Wainwright & Co., LLC
375
None
None
430 Park Avenue
4th Floor
New York
NY
NEW YORK
10022
CA
CALIFORNIA
FL
FLORIDA
IL
ILLINOIS
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
TX
TEXAS
4859092
4859092
0
The offering amount reflects the aggregate purchase price received and exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investors and placement agent in the private placement under Rule 506(b).
false
3
280000
0
In connection with the Registered Direct Offering concurrent with the Private Placement, the Placement Agent received $280,000.07 in fees and warrants to purchase up to 169,697 shares of common stock exerciseable at $2.0625 per share.
0
false
MAIA Biotechnology, Inc.
/s/ Vlad Vitoc
Vlad Vitoc
Chief Executive Officer
2023-11-29